Vaccine against Type 1 diabetes underway

Scientists at the University of Tampere in Finland and the Karolinska Institutet in Sweden have tested a vaccine targeting a pathogenic strain of an enterovirus in mice and found that it protected against Type 1 diabetes. The findings were reported in the 20 November 2017 edition of Diabetologia.

Full text available to subscribers only. Click here for information on subscribing to MedNous.